Pharmaceuticals: Major
Mexican companies operating in the same pharmaceuticals: major industry
The table below has Mexican companies that operate under the same industry, pharmaceuticals: major. This list helps you analyze each company’s performance, income statements, and stock activity — all in one place. Sort by key metrics to find the most expensive stocks like Eli Lilly and Company, or spot the most traded options, such as Genomma Lab Internacional SAB de CV Class B. Ideal for investors and traders looking to build or refine a strategy within this growing tech segment.
Symbol | Mkt cap | Price | Chg % | Vol | Rel vol | P/E | EPS dil TTM | EPS dil growth TTM YoY | Div yield % TTM | Sector | Analyst rating |
|---|---|---|---|---|---|---|---|---|---|---|---|
 LLYEli Lilly and Company | 19.73 T MXN | 20,820.85 MXN | +0.54% | 4.37 K | 3.36 | 41.79 | 498.22 MXN | +101.46% | 0.54% | Health technology | Buy |
| LLYEli Lilly and Company | 19.73 T MXN | 20,966.50 MXN | +1.23% | 101 | 0.51 | 42.08 | 498.22 MXN | +101.46% | 0.54% | Health technology | Buy |
 JNJJohnson & Johnson | 11.12 T MXN | 4,609.99 MXN | +2.01% | 77 | 0.63 | 30.53 | 151.02 MXN | −13.89% | 1.99% | Health technology | Buy |
| JNJJohnson & Johnson | 11.12 T MXN | 4,594.00 MXN | +1.68% | 64 | 0.92 | 30.42 | 151.02 MXN | −13.89% | 1.99% | Health technology | Buy |
 ABBVAbbVie, Inc. | 8.03 T MXN | 4,516.00 MXN | +2.87% | 12 | 0.03 | 124.20 | 36.36 MXN | −24.32% | 2.60% | Health technology | Buy |
| ABBVAbbVie, Inc. | 8.03 T MXN | 4,520.00 MXN | +0.52% | 31 | 0.08 | 124.31 | 36.36 MXN | −24.32% | 2.60% | Health technology | Buy |
 ROP1/NRoche Holding Ltd | 6.07 T MXN | 7,184.44 MXN | 0.00% | 1 | 0.00 | 21.65 | 331.88 MXN | +19.51% | 2.76% | Health technology | Buy |
 MRKMerck & Co., Inc. | 5.67 T MXN | 2,290.00 MXN | −0.40% | 185 | 0.07 | 35.94 | 63.72 MXN | −54.72% | 2.56% | Health technology | Buy |
| MRKMerck & Co., Inc. | 5.67 T MXN | 2,300.00 MXN | +0.77% | 214 | 0.03 | 36.09 | 63.72 MXN | −54.72% | 2.56% | Health technology | Buy |
 NOVN/NNovartis AG | 4.97 T MXN | 2,487.40 MXN | 0.00% | 529 | 1.30 | 21.85 | 113.84 MXN | −18.94% | 2.92% | Health technology | Neutral |
| NVS/NNovartis AG Sponsored ADR DR | 4.97 T MXN | 2,671.00 MXN | +2.02% | 12 | 0.47 | 23.02 | 116.03 MXN | −10.42% | 1.99% | Health technology | Neutral |
 AZN1/NAstraZeneca PLC | 4.58 T MXN | 2,964.41 MXN | 0.00% | 5.09 K | 2.63 | 25.19 | 117.68 MXN | +13.59% | 1.86% | Health technology | Buy |
| AZN1/NAstraZeneca PLC | 4.58 T MXN | 2,960.15 MXN | +1.12% | 286 | 1.20 | 25.15 | 117.68 MXN | +13.59% | 1.86% | Health technology | Buy |
 NOVOB/NNovo Nordisk A/S Class B | 3.78 T MXN | 890.77 MXN | 0.00% | 6 | 0.15 | 11.75 | 75.82 MXN | +8.96% | 3.65% | Health technology | Buy |
| NOVOB/NNovo Nordisk A/S Class B | 3.78 T MXN | 894.00 MXN | −0.33% | 20 | 0.62 | 11.79 | 75.82 MXN | +8.96% | 3.65% | Health technology | Buy |
| NVO/NNovo Nordisk A/S Sponsored ADR Class B DR | 3.78 T MXN | 850.02 MXN | +0.24% | 2.6 K | 1.42 | 11.12 | 76.42 MXN | +10.63% | 2.52% | Health technology | Buy |
 PFEPfizer Inc. | 2.45 T MXN | 429.08 MXN | −1.95% | 845 | 0.71 | 18.34 | 23.39 MXN | −17.18% | 7.01% | Health technology | Neutral |
| PFEPfizer Inc. | 2.45 T MXN | 430.01 MXN | −1.38% | 276 | 0.01 | 18.38 | 23.39 MXN | −17.18% | 7.01% | Health technology | Neutral |
 BMYBristol-Myers Squibb Company | 2.22 T MXN | 1,029.97 MXN | −5.51% | 5 | 0.05 | 16.12 | 63.89 MXN | +17.09% | 4.03% | Health technology | Buy |
| BMYBristol-Myers Squibb Company | 2.22 T MXN | 1,075.00 MXN | +1.65% | 10.72 K | 38.58 | 16.83 | 63.89 MXN | +17.09% | 4.03% | Health technology | Buy |
 VRTXVertex Pharmaceuticals Incorporated | 2.12 T MXN | 8,192.11 MXN | −1.89% | 6 | 0.02 | 27.08 | 302.51 MXN | — | 0.00% | Health technology | Buy |
| VRTXVertex Pharmaceuticals Incorporated | 2.12 T MXN | 8,626.62 MXN | +4.80% | 13 | 0.28 | 28.52 | 302.51 MXN | — | 0.00% | Health technology | Buy |
 SAN1/NSanofi SA | 1.83 T MXN | 1,532.71 MXN | +3.14% | 313 | 0.12 | 17.01 | 90.10 MXN | −5.69% | 5.42% | Health technology | Buy |
| SNY/NSanofi SA Sponsored ADR DR | 1.83 T MXN | 752.01 MXN | −3.03% | 74 | 0.14 | 17.47 | 43.04 MXN | −13.78% | 4.07% | Health technology | Buy |
 GSK/NGSK plc Sponsored ADRDR | 1.79 T MXN | 882.00 MXN | −3.82% | 40 | 0.14 | 12.86 | 68.58 MXN | +73.79% | 3.44% | Health technology | Buy |
 REGNRegeneron Pharmaceuticals, Inc. | 1.2 T MXN | 10,835.99 MXN | 0.00% | 5 | 0.03 | 14.72 | 736.04 MXN | −8.55% | 0.55% | Health technology | Buy |
| REGNRegeneron Pharmaceuticals, Inc. | 1.2 T MXN | 11,785.70 MXN | +11.27% | 2.02 K | 40.60 | 16.01 | 736.04 MXN | −8.55% | 0.55% | Health technology | Buy |
 BAYN/NBayer AG | 901.65 B MXN | 779.00 MXN | 0.00% | 2 | 0.30 | — | −45.47 MXN | +38.04% | 0.24% | Health technology | Buy |
 HLN1/NHaleon PLC Sponsored ADRDR | 746.64 B MXN | 164.00 MXN | −0.61% | 18 | 0.00 | 18.68 | 8.78 MXN | +4.88% | 1.87% | Health technology | Buy |
 ALNYAlnylam Pharmaceuticals, Inc | 635.57 B MXN | 5,549.00 MXN | +7.74% | 42 | 0.49 | 73.52 | 75.48 MXN | — | 0.00% | Health technology | Buy |
 RPRX/NRoyalty Pharma Plc Class A | 593.43 B MXN | 1,025.44 MXN | 0.00% | 106 | 0.05 | 29.95 | 34.24 MXN | −31.84% | 1.55% | Health technology | Strong buy |
 ZTSZoetis, Inc. Class A | 553.32 B MXN | 1,295.00 MXN | 0.00% | 1 | 0.00 | 11.96 | 108.25 MXN | −5.12% | 2.73% | Health technology | Buy |
| ZTSZoetis, Inc. Class A | 553.32 B MXN | 1,353.45 MXN | +1.94% | 38 | 0.35 | 12.50 | 108.25 MXN | −5.12% | 2.73% | Health technology | Buy |
 4568/NDaiichi Sankyo Company, Limited | 544.57 B MXN | 286.67 MXN | 0.00% | 200 | 0.00 | 18.08 | 15.85 MXN | −25.53% | 2.79% | Health technology | Strong buy |
 BIIBBiogen Inc. | 522.87 B MXN | 3,678.00 MXN | +0.59% | 58 | 0.20 | 22.01 | 167.11 MXN | −19.45% | 0.00% | Health technology | Buy |
| BIIBBiogen Inc. | 522.87 B MXN | 3,434.49 MXN | −9.14% | 5 | 0.02 | 20.55 | 167.11 MXN | −19.45% | 0.00% | Health technology | Buy |
 INCYIncyte Corporation | 411.78 B MXN | 2,036.00 MXN | +1.50% | 9.71 K | 19.19 | 16.05 | 126.82 MXN | +1,815.31% | 0.00% | Health technology | Buy |
| INCYIncyte Corporation | 411.78 B MXN | 1,997.00 MXN | +21.62% | 1.37 K | 8.02 | 15.75 | 126.82 MXN | +1,815.31% | 0.00% | Health technology | Buy |
 INSMInsmed Incorporated | 405.94 B MXN | 1,895.00 MXN | −19.87% | 100 | — | — | −103.00 MXN | +15.46% | 0.00% | Health technology | Strong buy |
| INSMInsmed Incorporated | 405.94 B MXN | 1,981.33 MXN | +2.39% | 208 | 0.17 | — | −103.00 MXN | +15.46% | 0.00% | Health technology | Strong buy |
 VTRSViatris, Inc. | 354.43 B MXN | 295.00 MXN | +3.79% | 545 | 1.02 | — | −4.64 MXN | +92.87% | 2.78% | Health technology | Buy |
| VTRSViatris, Inc. | 354.43 B MXN | 299.99 MXN | +4.50% | 422 | 4.19 | — | −4.64 MXN | +92.87% | 2.78% | Health technology | Buy |
 IPN/NIpsen SA | 261.05 B MXN | 3,384.27 MXN | +21.13% | 315 | 0.23 | 30.05 | 112.63 MXN | +25.81% | 1.01% | Health technology | Buy |
 REC/NRecordati S.p.A. | 211.15 B MXN | 1,019.79 MXN | 0.00% | 1.59 K | 1.01 | 21.83 | 46.72 MXN | +5.46% | 2.61% | Health technology | Buy |
 4528/NONO Pharmaceutical Co., Ltd. | 122.25 B MXN | 341.69 MXN | 0.00% | 600 | 0.04 | 20.38 | 16.76 MXN | +15.27% | 3.29% | Health technology | Neutral |
 ACADACADIA Pharmaceuticals Inc. | 74.51 B MXN | 453.75 MXN | +2.89% | 200 | 0.30 | 11.52 | 39.39 MXN | +39.96% | 0.00% | Health technology | Buy |
 OGNOrganon & Co. | 62.19 B MXN | 220.00 MXN | −8.33% | 55 | 0.40 | 13.07 | 16.83 MXN | −71.56% | 0.59% | Health technology | Neutral |
| OGNOrganon & Co. | 62.19 B MXN | 225.00 MXN | −1.75% | 9 | 0.14 | 13.37 | 16.83 MXN | −71.56% | 0.59% | Health technology | Neutral |
 ATAIAtaiBeckley Inc. | 46.53 B MXN | 125.49 MXN | +37.30% | 881 | — | — | −40.15 MXN | −1,045.90% | 0.00% | Health technology | Neutral |
| ATAIAtaiBeckley Inc. | 46.53 B MXN | 92.65 MXN | +19.58% | 115 | — | — | −40.15 MXN | −1,045.90% | 0.00% | Health technology | Neutral |
 PRGO/NPerrigo Co. Plc | 24.45 B MXN | 557.52 MXN | 0.00% | 1 | 0.00 | — | −235.02 MXN | −804.12% | 11.50% | Health technology | Buy |
 LAB/BGenomma Lab Internacional SAB de CV Class B | 14.45 B MXN | 14.50 MXN | +3.57% | 300.2 K | 1.75 | 8.72 | 1.66 MXN | −19.16% | 5.54% | Health technology | Buy |
| LAB/BGenomma Lab Internacional SAB de CV Class B | 14.45 B MXN | 14.45 MXN | +2.77% | 4.09 M | 1.21 | 8.69 | 1.66 MXN | −19.16% | 5.54% | Health technology | Buy |
 OCGNOcugen Inc | 7.17 B MXN | 21.42 MXN | −4.37% | 38 | 0.12 | — | −4.16 MXN | −8.52% | 0.00% | Health technology | Strong buy |
| OCGNOcugen Inc | 7.17 B MXN | 21.47 MXN | −4.15% | 141 | 0.79 | — | −4.16 MXN | −8.52% | 0.00% | Health technology | Strong buy |
 INOInovio Pharmaceuticals, Inc. | 1.4 B MXN | 19.50 MXN | −8.36% | 5 | 0.16 | — | −30.63 MXN | +53.08% | 0.00% | Health technology | Buy |
| INOInovio Pharmaceuticals, Inc. | 1.4 B MXN | 19.00 MXN | 0.00% | 1 | 0.03 | — | −30.63 MXN | +53.08% | 0.00% | Health technology | Buy |
 KYNBKyntra Bio, Inc. | 498.48 M MXN | 127.90 MXN | 0.00% | 4 | 0.06 | 0.26 | 492.58 MXN | — | 0.00% | Health technology | Buy |
 ATOSAtossa Therapeutics, Inc. | 400.99 M MXN | 40.00 MXN | 0.00% | 33 | 0.37 | — | −78.36 MXN | −22.76% | 0.00% | Health technology | Strong buy |
| ATOSAtossa Therapeutics, Inc. | 400.99 M MXN | 41.50 MXN | +3.75% | 44 | 0.88 | — | −78.36 MXN | −22.76% | 0.00% | Health technology | Strong buy |